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A B S T R A C T
Juglans regia L. (walnut tree) is a recognized source of bioactive compounds with potential health benefits. In this
work, hydroethanolic extracts of J. regia leaves were obtained by heat assisted extraction from different
Portuguese samples in two phenological stages (green and yellow leaves) aiming to assess the impact of seasonal
variations. The samples were compared regarding their phenolic composition and bioactivity. Seventeen phe-
nolic compounds were identified by liquid chromatography combined with a diode array detector and elec-
trospray ionization mass spectrometer (LC-DAD-ESI/MSn): six phenolic acids, ten flavonoids and one tetralone
derivative. The green leaves extracts presented a higher amount of total phenolic compounds
(29.70 ± 0.03mg/g extract) compared with the yellow leaves (23.26 ± 0.06mg/g extract). In particular,
yellow samples were richer in flavonoids (17.4 ± 0.2mg/g extract; mainly quercetin-3-O-glucoside:
3.64 ± 0.01mg/g extract), while the green ones presented higher phenolic acids content (16.7 ± 0.2mg/g
extract; mainly trans 3-p-coumaroylquinic acid: 6.9 ± 0.5mg/g extract). Green leaves extract also presented
higher antioxidant potential, achieving IC50 values around 32 ± 2 μg/mL and 26.8 ± 0.2 μg/mL for the oxi-
dative haemolysis inhibition and the thiobarbituric acid reactive substances assays, respectively. Furthermore,
only green leaves samples showed anti-inflammatory potential. The cytotoxic evaluations revealed similar anti-
proliferative action of both extracts against the tumor cell lines tested. Also, an analogous anti-bacterial potential
of the extracts was observed, with preferential action against Gram-positive clinical isolated bacteria, with lower
minimum inhibitory concentration (MIC) values for Enterococcus faecalis and Listeria monocytogenes
(MIC=2.5mg/mL). Therefore, the present study suggests the use of walnut leaves as a source of active in-
gredients without hepatotoxic effects to be used in different applications in the food or pharmaceutical areas.
1. Introduction
Medicinal plants have been used for centuries by different civiliza-
tions as therapeutic agents due to their preventive and curative prop-
erties (Tasneem et al., 2019). Juglans regia L. is spread across the globe,
being walnut leaves widely used by the folk medicine as antiseptic, anti-
inflammatory, antidiabetic, anti-helminthic and antidiarrheic agents.
Furthermore, they are also traditionally used for the treatment of hy-
perhidrosis, ulcers and dandruff (Carvalho et al., 2010a; Cosmulescu
et al., 2014). Moreover, J. regia leaves extract is an inventoried in-
gredient for cosmetic products, with reported astringent, soothing,
cleansing, abrasive, bulking, skin conditioning, and masking functions
(European Commission, 2006).
Many studies reported the bioactivity of walnut leaves by several in
vitro (cell cultures) and in vivo (rats/mice) assays regarding their anti-
diabetic (Asgary et al., 2008; Hosseini et al., 2014; Javidanpour et al.,
2012; Mohammadi et al., 2012; Mollica et al., 2017; Pitschmann et al.,
2014; Teimori et al., 2009), anti-inflammatory (Erdemoglu et al., 2003;
Hosseinzadeh et al., 2011), anti-proliferative (Salimi et al., 2014;
Santos et al., 2013), anti-septic/biofilm/bacterial (Dolatabadi et al.,
2018; Pereira et al., 2007), hepatoprotective (Eidi et al., 2013), sedative
and analgesic (Erdemoglu et al., 2003; Gîrzu et al., 1998; Hosseinzadeh
et al., 2011), vasorelaxant (Perusquía et al., 1995), and neuroprotective
(Orhan et al., 2011) properties. The study performed by Wang et al.
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(2015) evaluated the anti-hyperuricemia potential of J. regia leaves by
determining the xanthine oxidase inhibitory activity. Moreover, the
extensive evidences on the anti-diabetic activity of walnut leaves en-
couraged Abdoli et al. (2017) to carry out a human trial using walnut
leaves-based preparations in Type II diabetic patients, obtaining posi-
tive results for the reduction of the glycemic index and HbA1c (glycated
hemoglobin) values.
The secondary metabolites of J. regia leaves have been related to its
therapeutic effects, such compounds including phenolic acids, flavo-
noids, organic acids, tocopherols, triterpenic acids, terpenes, terpe-
noids, tetralone derivatives, megastigmane derivatives, hydroxy-1,4-
naphthoquinone (juglone) derivatives, among others (Cosmulescu
et al., 2011; Forino et al., 2016; Panth et al., 2016; Rather et al., 2012;
Salimi et al., 2014; Santos et al., 2013; Schwindl and Kraus, 2017).
Phenolic compounds are the main fraction found in the plant material.
They are natural occurring antioxidants, largely recognized because of
their health benefits due to their radical scavenging activity, reducing
oxidative stress, which is the main cause of several disorders. In fact,
these exogenous antioxidant source play an important role for the
oxidative stress balance, providing additional antioxidant potential for
living organisms, since there is an insufficient action of our endogenous
antioxidant system (Carocho and Ferreira, 2013). In this context, the
inclusion of walnut leaves preparations (food and supplements) in our
diet could act as a preventive medicine with several health benefits
(Pires et al., 2018).
The use of J. regia leaves goes back from centuries, and in Portugal,
especially in the northeast region (Bragança) they are traditionally used
as an external antiseptic, anti-inflammatory and antidiabetic agent
(Carvalho et al., 2010a). In this context, the study of walnut leaves from
this region, characterizing their main constituents and potential
bioactivities, will contribute to support their traditional medicinal uses
with scientific evidences, valorizing this species and its origin. In this
work, Portuguese walnut leaves in two phenological stages (green and
yellow leaves) were evaluated aiming to assess the impact of seasonal
variations on the phenolic compounds composition and the bioactive
potential of the extracts obtained. The seasonal variation of the phy-
tochemical profile of this plant material has been previously established
by Cosmulescu et al. (2014) using Romanian samples. Along that study,
samples were collected during each fortnight from 1 st of June to 15th
of August 2012 and were only compared in terms of their phyto-
chemical abundancy (ellagic acid, rutin, myricetin and juglone).
In order to achieve the aims proposed in this study, a hydro-
ethanolic extract was evaluated regarding its antioxidant, cytotoxic and
antibacterial activities, and the phenolic profile was obtained by LC-
DAD-ESI/MSn.
2. Material and methods
2.1. Plant material and extract preparation
Juglans regia L. (walnut) leaves were collected in Bragança,
Northeast of Portugal, in May (green leaves) and November (yellow
leaves) of 2018. The samples were dried until constant weight in an
incubator at 35 °C. Then, the plant material was ground to approxi-
mately 40 mesh, and the homogeneous samples were stored in a de-
siccator protected from light.
The hydroethanolic extract was obtained by heat assisted extrac-
tion, using the previous optimized conditions for the extraction of
phenolic compounds reported by the authors (Vieira et al., 2017):
aqueous ethanolic solution (50.4%, v/v; 30 g/mL) at 61.3 °C for
116min. After filtration (Whatman no. 4 filter), the solvent was first
evaporated at 40 °C, under reduced pressure, in a rotary evaporator
(Büchi R-210, Flawil, Switzerland) and the residual solvent was re-
moved in a freeze drier (Telstar Cryodos-80, Terrassa, Barcelona).
2.2. Phenolic compounds characterization
The dry extracts were re-suspended at a concentration of 10mg/mL
using aqueous ethanol (20%, v/v) and filtered (0.2 μm disposable LC
filter disk, 30mm, nylon). Afterwards, the phenolic profile of walnut
leaves was found by liquid chromatography with diode-array detector
(280, 330, and 370 nm wavelengths) coupled to an electrospray ioni-
zation mass spectrometry operating in negative mode (Dionex Ultimate
3000 UPLC and Linear Ion Trap LTQ XL, Thermo Scientific, San Jose,
CA, USA), as previously described by the authors (Bessada et al., 2016).
The phenolic compounds were identified according to their chromato-
graphic characteristics by comparison to those obtained with standard
compounds and with literature. Calibration curves of appropriate
standards were obtained in the range 200-5 μg/mL, for the quantitative
analysis. The results were expressed in mg per g of extract (mg/g).
2.3. In vitro antioxidant assays
The lipid peroxidation inhibition in porcine (Sus scrofa) brain
homogenates was evaluated through the thiobarbituric acid reactive
substances (TBARS) assay. The ethanolic extracts were prepared at a
concentration of 10mg/mL in distilled water and further successive
dilutions were performed to obtain the working concentrations ranging
from 400 to 6.25 μg/mL. The decrease of the TBARS production was
performed by measuring the color intensity of the malondialdehyde-
thiobarbituric acid (MDA-TBA) at 532 nm. The methodology followed
was previously reported by Barreira et al. (2013) with slight mod-
ifications. Briefly, dissected porcine brain was homogenized with
Tris−HCl buffer (20mM, pH 7.4) at a ratio of 1:2 (w/v). The homo-
genate was centrifuged (3000 rpm for 10min) and an aliquot (100 μL)
of the supernatant was incubated with the stock solutions of extract
(200 μL), FeSO4 (10mM; 100 μL) and ascorbic acid (0.1 mM; 100 μL) at
37 °C for 60min. Then, the reaction was stopped by adding tri-
chloroacetic acid (28%, w/v, 500 μL), thiobarbituric acid (2%, w/v,
380 μL), and heating the mixture at 80 °C for 20min. After that, the
mixtures were centrifuged (3000 rmp) for 10min and the absorbances
of the supernatants were measured. The inhibition ratio (%) was cal-
culated using the following formula: [(A− B)/A]×100%, being A and
B the absorbance of the control and the sample solution, respectively.
The EC50 value defines the concentration providing 50% of antioxidant
activity, and was calculated by interpolation from the graph of TBARS
formation inhibition percentage against sample concentration.
The anti-haemolytic activity of walnut leaves samples was evaluated
by the oxidative haemolysis inhibition assay (OxHLIA). The adopted
methodology was previously described by Takebayashi et al. (2012);
however, slight modifications were implemented. Erythrocytes were
obtained from sheep blood collection. Healthy animals were selected
for the purpose and the full blood was centrifuged at 1000g at 10 °C for
5min. Then, plasma and buffy coats were discarded and erythrocytes
were once washed with NaCl (150 nM) and three times with phosphate
buffer solution (PBS, pH 7.4) (Evans et al., 2013), being the erythrocyte
fraction resuspended in PBS (2.8%, v/v). The extract was dissolved in
PBS (pH 7.4) to obtain a stock solution of 10mg/mL, and successive
solutions were prepared, ranging from 400 to 6.25 μg/mL. About
400 μL of each solution was transferred for a 48 well plate (duplicates).
Water and PBS (pH 7.4) were used as controls of haemolysis (plasmo-
lytic and isotonic media, respectively) and Trolox as positive control.
Then, the suspension of erythrocytes (200 μL) was mixed with the
previous solutions/controls and the 48-well plate was incubated for
10min at 37.5 °C with agitation. After that, a solution of 2,2′-azobis(2-
methylpropionamidine) dihydrochloride (AAPH, 160mM in PBS,
200 μL) was added and the absorbance of the mixtures was measured at
690 nm (BioTek ELx800). The microplate was incubated under the
same conditions and absorbances were measured every 10min during
approximately 400min. The percentage of the erythrocyte population
that remained intact (P) was calculated using the following equation:
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P (%)= (St −CH0/S0 −CH0)× 100
where St and S0 correspond to the absorbance of the sample at time t
and 0min, respectively, and CH0 is the absorbance of the complete
haemolysis at 0min. The results were, then, expressed as delayed time
of haemolysis (Δt), which was calculated according to the following
equation:
Δt (min)=Ht50 (sample) –Ht50 (control)
where Ht50 is the haemolytic time (minutes) obtained by graphical
representation of the haemolysis curve of each sample concentration.
Then, the Δt values were correlated to the antioxidant sample con-
centrations promoting the desirable Δt haemolysis delay (Takebayashi
et al., 2012). The results were expressed as IC50 values (μg/mL) at
60min, meaning the extract concentration required to keep 50% of the
erythrocytes intact for 60min.
2.4. Anti-inflammatory activity
The walnut leaves extracts were re-dissolved in water at a con-
centration of 8mg/mL and then diluted in the range of 400 to 6.25 μg/
mL using supplemented DMEM (10% heat-inactivated fetal bovine
serum, 2mM glutamine, 10% MEM non-essential amino acids solution,
100 U/mL penicillin and 100 μg/mL streptomycin). A mouse macro-
phage-like cell line RAW264.7 was used in this study and maintained at
37 °C under 5% of CO2. Briefly, a suspension of cells (5× 105 cells/mL)
was allowed to sediment on the 96-well plate (1.5× 105 cells/well)
overnight. Then, cells were treated with the different concentrations of
extract for 60min. Thereafter, the cells were stimulated with LPS
(1 μmg/mL, in supplemented DMEM) during 18 h. Besides the GRS, the
kit contains sulfanilamide, N-(1-naphthyl)ethylenediamine dihy-
drochloride (NED) and nitrite solutions. The cell culture supernatant
(100 L) was transferred to the plate in duplicate and mixed with sul-
fanilamide and NED solutions, 5 and 10min each, at room temperature.
The nitrite produced was determined by measuring the optical density
at 515 nm, using the ELx800 microplate reader (Bio-Tek Instruments,
Inc; Winooski, VT, USA) following a methodology previously reported
(Correa et al. 2015). The results were expressed in EC50 values (sample
concentration providing 50% of inhibition of NO production) and
dexamethasone was used as a positive control, while in negative con-
trols no LPS was added.
2.5. Cytotoxic assays
The extracts were re-dissolved in water at 8mg/mL concentration
and further diluted in the range 400 to 6.25 μg/mL. The four human
tumor cell lines assessed (MCF-7, breast adenocarcinoma; NCI-H460,
non-small cell lung cancer; HeLa, cervical carcinoma; and HepG2, he-
patocellular carcinoma) were maintained as adherent cell cultures in
RPMI-1640 medium containing heat-inactivated fetal bovine serum
(FBS, 10%), glutamine (2mM), MEM non-essential amino acids solution
(10%), and antibiotics (100 U/mL penicillin and 100mg/mL strepto-
mycin) at 37 °C, in a humidified air incubator with CO2 (5%). For
evaluation of the cytotoxicity in non-tumor cells, a cell culture desig-
nated as PLP2, was prepared from a freshly harvested porcine liver
obtained from a local slaughterhouse, according to a procedure estab-
lished by Abreu et al. (2011). The cell proliferation of each cell culture
was monitored every two to three days using a phase contrast micro-
scope and, before confluence was reached, the cells were subcultured in
the supplemented RPMI-1640 medium mentioned above. Then, the
cells were distributed in 96-well-plates (190 μL) according to their ap-
propriate density (1.0× 104 cells/well for all cell cultures) and tested
with the solutions of extracts (10 μL) during 48 h. Ellipticine was used
as positive control. Hereinafter, the adherent cells were fixed by adding
trichloroacetic acid (TCA, 10%, 100 μL) and incubation at 4 °C for
60min. After the incubation period, the TCA was removed and plates
were washed (distilled water, three times) and dried. The sulforhoda-
mine B solution (SRB, 0.1% in 0.1% acetic acid, 100 μL) was then added
and allowed to bound at room temperature for 30min. The excess of
SRB was removed by washing the 96-well plates with acetic acid (1%,
three times) and allowed to dry. The bound SRB was solubilized by
adding Tris buffer solution (10mM, 200 μL) and the absorbances were
measured at 540 nm using the microplate reader mentioned above. The
results were expressed in GI50 values (concentration that inhibited 50%
of the cell proliferation), being the negative control constituted by each
suspension of cells (Barros et al., 2013).
2.6. Antibacterial activity
The antimicrobial potential of the walnut husks was assessed for
bacterial strains obtained from patients hospitalized in different de-
partments at the Northeastern local health unit (Bragança, Portugal)
and Hospital Center of Trás-os-Montes and Alto Douro (Vila Real,
Portugal). Five Gram-negative bacteria (Escherichia coli, isolated from
urine; Proteus mirabilis, isolated from wound exudate; Klebsiella pneu-
moniae, isolated from urine; Pseudomonas aeruginosa, isolated from ex-
pectoration; and Morganella morganii, isolated from urine), three Gram-
positive bacteria (Enterococcus faecalis, isolated from urine; Listeria
monocytogenes, isolated from cerebrospinal fluid; methicillin-resistant
Staphylococcus aureus (MRSA), isolated from expectoration) were tested.
All these microorganisms were incubated at 37 °C in appropriate fresh
medium for 24 h before analysis to maintain the exponential growth
phase. The minimum inhibitory concentration (MIC) determinations on
all bacteria were performed using a colorimetric assay described by
Pires et al. (2018).
The extracts were dissolved in a mixture of dimethyl sulfoxide
(DMSO) + Mueller-Hinton Broth (MHB; E. coli, P. mirabilis, K. pneu-
moniae, P. aeruginosa, M. morganii and MRSA)/ Tryptic Soy Broth (TSB,
E. faecalis and L. monocytogenes) (5+ 95%, v/v) to give a final con-
centration of 100mg/mL for the stock solution and successive dilutions
were further carried out ranging from 20 to 1.25mg/mL. Then, 90 μL of
each concentration and 10 μL of each inoculum (standardized at
1.5× 108 Colony Forming Unit (CFU)/mL) were pipetted (duplicates)
for a 96-well microplate. Three negative controls were prepared (1:
MHB/ TSB; 2: extract; 3: medium+antibiotic+ bacteria), whereas,
the positive control was prepared with MHB/TSB and each inoculum.
The Ampicillin and Imipenem antibiotics were used as negative control
for all Gram-negative bacteria tested and Listeria monocytogenes, while
Ampicillin and Vancomycin were selected for Enterococcus faecalis and
MRSA. The microplates were covered and incubated at 37 °C for 24 h.
The MIC of samples was detected following addition of p-iodonitrote-
trazolium chloride (INT) (0.2 mg/mL, 40 μL) and further incubation at
37 °C for 30min. MIC was defined as the lowest concentration that
inhibits the bacterial growth, determined visually by change of the
coloration from yellow to pink (viable microorganism) as previously
described by Kuete et al. (2011). To determine the minimum bacter-
icidal concentration (MBC), 10 μL of liquid from each well that showed
no change in colour was inoculated on Blood agar solid medium (7%
sheep blood) and incubated at 37 °C for 24 h. The MBC was determined
according to the lowest concentration that yielded no growth. Mean-
while, MBC was established as the lowest concentration required to kill
bacteria.
2.7. Statistical analysis
Triplicates of green and yellow samples were assayed and three
repetitions of each methodology were performed, being the results
expressed as mean values and standard deviations (SD). The significant
differences between the two samples were established by applying a
Student´s t-test, with p= 0.05 (SPSS v. 23.0 program).
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3. Results and discussion
3.1. Composition in phenolic compounds
The phenolic composition of the extracts of J. regia leaves was as-
sessed for samples in two phenological stages (green and yellow sam-
ples, collected in May and November, respectively). The identified
molecules and their quantification are presented in Table 1. In this
context, phenolic compounds were tentatively identified according to
their retention time (Rt), maximum absorbance wavelength (λmax),
pseudomolecular ion ([M−H]–), and respective fragmentation pattern
(MS2). For both samples, it was possible to identify seventeen phenolic
compounds: six phenolic acids (p-hydroxycinnamic acid derivatives),
ten flavonoids (flavonols) and one tetralone derivative (Fig. 1).
Regarding the six phenolic acids identified in J. regia, peak 1
([M−H]– at m/z 341), 6 ([M−H]– at m/z 355), and 7 ([M−H]– at m/z
325) were tentatively identified as caffeic, ferulic, and p-coumaric acid
hexosides, based on the signal MS2 fragment at m/z 179 [caffeic acid –
H]–, 193 [ferulic acid – H]–, and 163 [p-coumaric acid – H]–, respec-
tively, revealing the loss of a hexosyl moiety (−162 u). The first two
compounds were previously identified byGawlik-Dziki et al. (2014),
however, to the best of our knowledge, ferulic acid hexoside has not
been previously identified in J. regia leaves, hence the free forms of
these phenolic acids have also been previously identified (Wichtl and
Anton, 1999). Peak 2 ([M−H]– at m/z 353) and peaks 3 and 4
([M−H]– at m/z 337) were assigned as trans 3-O-caffeoylquinic acid
and cis and trans 3-p-coumaroylquinic acid, respectively. These as-
sumptions were taken into account, due to the hierarchical fragmen-
tation pattern described by Clifford et al. (2003), but also by using
literature data described by other authors, that identified these com-
pounds in J. regia leaves (Amaral et al., 2004; Santos et al., 2013; Wichtl
and Anton, 1999).
Peak 5 ([MeH]– at m/z 353) belongs to a different group of
phenolic molecules, the tetralone derivatives. This type of molecules
was already reported in Juglans species. The fragmentation yielded the
ion at m/z 159 ([MeH]– - H2O – 180, loss of a hexosyl unit and a
neutral loss of water) corresponding to the dihydroxytetralone. This
molecule frequently occurs in branches, fruit and pericarps/husks of J.
mandshurica samples (Bi et al., 2016; Gawlik-Dziki et al., 2014; Jin-Hai
et al., 2018; Liu et al., 2004; Wang et al., 2017; Zhou et al., 2015) and J.
sigillata pericarps (Liu et al., 2010). To the best of our knowledge, it is
the first time that the presence of dihydroxytetralone hexoside is re-
ported as a phenolic constituent in J. regia leaves. Thus, a similar
fragmentation pattern ([MeH]– at m/z 339, with a fragment at 159,
UV–vis maximum absorption, 258, 313 nm) was previously found by
Gawlik-Dziki et al. (2014) in J. regia leaves and pericarps. Nevertheless,
the authors stated the molecule as an unknown phenolic compound
(Gawlik-Dziki et al., 2014).
The last group of molecules were identified as flavonol glycoside
derivatives, such as myricetin, quercetin and kaempferol derivatives.
Compounds 8 (myricetin-3-O-glucoside), 10 (quercetin-3-O-glucoside),
and 13 (kaempferol-3-O-glucoside) were positively identified by com-
parison with the corresponding commercial standards. The remaining
compounds (peaks 9, 11, 12, and 14–17) were identified as quercetin
(λmax= 350 nm; MS2 fragment at m/z 301), kaempferol
(λmax= 348 nm; MS2 fragment at m/z 285), and myricetin
(λmax= 350 nm, MS2 fragment at m/z 317), showing a MS2 fragmen-
tation pattern with different losses of hexosyl (−162 u), pentosyl
(−132 u), and rhamnosyl (−146 u) residues, being assigned as myr-
icetin-O-rhamnoside (peak 9), quercetin-O-hexoside (peak 11), quer-
cetin-O-pentoside (peaks 12 and 14), quercetin-O-rhamnoside (peak
15), and kaempferol-O-pentoside (peak 16). The majority of the iden-
tified compounds have been previously identified by Santos et al.
(2013). Finally, peak 17 ([MeH]– at m/z 489) presented 42 u (acetyl
moiety) higher then compound 15 (quercetin-O-rhamnoside), being
therefore tentatively identified as acetylquercetin-O-rhamnoside. In
Table 1
Retention time (Rt), wavelengths of maximum absorption in the visible region (λmax), mass spectral data, tentative identification, and quantification estimation
(mean ± SD) of the tentatively identified phenolic compounds in green and yellow leaves extracts of J. regia.










1 4.48 324 341 179(100) Caffeic acid hexosidea 1.80 ± 0.08 0.44 ± 0.01 < 0.001
2 5.14 324 355 191(100),179(46),173(7),161(5),135(11) 3-O-Caffeoylquinic acida 3.5 ± 0.4 0.191 ± 0.005 <0.001
3 5.92 312 337 191(12),173(6),163(100),155(5),119(6) cis 3-p-Coumaroylquinic
acida
2.34 ± 0.08 0.99 ± 0.01 < 0.001
4 6.34 312 337 191(19),163(100),155(5),119(6) trans 3-p-Coumaroylquinic
acida
6.9 ± 0.5 2.87 ± 0.09 < 0.001
5 8.46 310 339 159(100),115(52) Dihydroxytetralone
hexosideb,c
nq nq –
6 9.28 320 355 193(100),175(20) Ferulic acid hexosided 0.73 ± 0.06 0.46 ± 0.01 < 0.001
7 9.85 312 325 163(100) p-Coumaric acid hexosidea 1.43 ± 0.03 0.91 ± 0.03 < 0.001
8 15.3 350 479 317(100) Myricetin-3-O-glucosided,f 0.97 ± 0.05 0.87 ± 0.01 0.010
9 17.87 350 463 317(100) Myricetin-O-rhamnosidef 0.78 ± 0.01 0.83 ± 0.03 0.038
10 18.73 353 463 301(100) Quercetin-3-O-glucosided,f 2.79 ± 0.02 3.64 ± 0.01 < 0.001
11 19.2 353 463 301(100) Quercetin-O-hexosidef 2.28 ± 0.2 2.75 ± 0.03 0.005
12 20.75 350 433 301(100) Quercetin-O-pentosidef 0.67 ± 0.02 0.857 ± 0.005 <0.001
13 21.47 347 447 285(100) Kaempferol-3-O-
glucosided
1.12 ± 0.01 1.27 ± 0.02 < 0.001
14 21.8 351 433 301(100) Quercetin-O-pentosidef 1.43 ± 0.02 3.21 ± 0.03 < 0.001
15 22.78 350 447 301(100) Quercetin-O-rhamnosidef 1.6 ± 0.1 2.13 ± 0.05 0.001
16 24.62 348 417 285(100) Kaempferol-O-pentosidef 0.721 ± 0.002 1.03 ± 0.04 < 0.001
17 28.86 340 489 447(33),301(100) Acetylquercetin O-
rhamnosided
0.627 ± 0.005 0.81 ± 0.01 < 0.001
Total phenolic acids 16.7 ± 0.2 5.9 ± 0.1 < 0.001
Total flavonoids 13.0 ± 0.2 17.4 ± 0.2 < 0.001
Total phenolic compounds 29.70 ± 0.03 23.26 ± 0.06 < 0.001
Calibration curves: Peaks 1 and 2: caffeic acid (y=388345x + 406369; r2=0.994; LOD=0.78 μg/mL; LOQ=1.97 μg/mL); peaks 3, 4 and 7: p-coumaric acid
(y= 301950x + 6966.7; r2=0.999; LOD=0.68 μg/mL; LOQ=1.61 μg/mL); peak 6: ferulic acid (y=63326x – 185462; r2=0.999 LOD=0.20 μg/mL; 1.01 μg/
mL); peaks 8 to 17: quercetin 3-O-glucoside (y=34843x – 160173; r2=0.9998; LOD=0.21 μg/mL; LOQ=0.71 μg/mL).
References applied for the tentative identification: a – Clifford et al. (2003), Clifford et al. (2005); b –Wang et al. (2017), c –Jin-Hai et al. (2018); d- standard, DAD
and MS fragmentation pattern; f – Santos et al. (2013).
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fact, the occurrence of acetyl-quercetin derivatives (and kaempferol as
well) in J. regia leaves has been also previously described by Gawlik-
Dziki et al. (2014).
Regarding the general profile of the samples (Table 1), green leaves
were mostly composed by phenolic acids (green samples:
16.7 ± 0.2mg/g extract; yellow samples: 5.9 ± 0.1 mg/g extract),
while the yellow ones by flavonoids (green samples: 13.0 ± 0.2mg/g
extract; yellow samples: 17.4 ± 0.2mg/g extract). Overall, the green
leaves of J. regia showed a significant higher amount of total phenolic
compounds (29.70 ± 0.03mg/g extract) in comparison to the yellow
samples (23.26 ± 0.06mg/g extract). As previous referred, phenolic
acids found in walnut leaves were essentially hydroxycinnamic acids
derivatives, being the trans 3-p-coumaroylquinic acid the most abun-
dant phenolic acid for both samples (6.9 ± 0.5 and 2.87 ± 0.09mg/g
extract, for green and yellow leaves, respectively). The presence of
hydroxycinnamic acid derivatives in J. regia leaves is common, re-
gardless of the cultivar or their maturity stage, raising the importance
of walnut leaves as a source of this type of bioactive compounds
(Amaral et al., 2004; Gawlik-Dziki et al., 2014; Pereira et al., 2007;
Pitschmann et al., 2014; Santos et al., 2013; Vieira et al., 2018, 2017;
Wojdylo et al., 2007). Regarding the relative abundancy of 3-p-cou-
maroylquinic acid isomers as the main phenolic acids in walnut leaves
samples, that is not frequent; in fact, caffeoylquinic acids have been
found as the main phenolic acids. In this context, 3-O-caffeoylquinic
acid was reported as the most abundant phenolic acid in several studies
(Amaral et al., 2004; Pereira et al., 2007; Santos et al., 2013; Vieira
et al., 2017, 2018), while 5-O-caffeoylquinic acid was found in higher
concentrations in Chinese samples (Zhao et al., 2014). On the other
hand, ellagic acid was the main phenolic acid for Romanian samples
(Pedro cultivar: 1.345mg/g of plant dw), and caffeic acid for Polish
samples (1.48 mg/g of plant dw) (Wojdylo et al., 2007). Despite the
atypical relative abundancy of 3-p-coumaroylquinic acid isomers, it is
relevant to mention that this compound frequently occurs in walnut
leaves (Gawlik-Dziki et al., 2014; Pitschmann et al., 2014). Regarding
the amounts found in Portuguese samples, Amaral et al. (2004) re-
ported concentrations about 0.38 to 2.59mg/g of plant dw and Pereira
et al. (2007) from 4.69 to 5.99mg/g of plant dw, depending on the J.
regia cultivar, while Santos et al. (2013) obtained from 0.92 to 1.2mg/g
of plant dw. Finally, Zhao et al. (2014) quantified lower values,
reaching 0.00672mg/g of plant dw in Chinese walnut leaves.
In general, the amount of the individual flavonoids in J. regia leaves
was significantly higher for the yellow samples. Quercetin-3-O-gluco-
side was the most abundant flavonoid for both samples, with yields of
3.64 ± 0.01 and 2.79 ± 0.02mg/g of extract in the yellow and green
leaves extracts, respectively. Quercetin-O-pentoside (peak 14) was the
second main flavonoid in J. regia yellow leaves (3.21 ± 0.03mg/g
extract) and the third for the green samples (1.43 ± 0.02mg/g ex-
tract). This tendency was also found by other authors (Santos et al.,
2013; Vieira et al., 2017, 2018). In this regard, Santos et al. (2013)
found quercetin-3-O-glucoside concentrations around 2.37 to 2.56mg/
g of plant dw, and, 0.38 to 5.04mg/g of plant dw for quercetin-O-
pentoside for the methanolic extract and decoction, respectively.
Higher amounts were found in Spanish hydroethanolic extracts by
Vieira et al. (2017), achieving 13.8 to 14.2 mg/g of plant dw for
quercetin-3-O-glucoside and 11.7 to 14.0 mg/g of plant dw, depending
on the extraction methodology. Later, the authors increased the ex-
traction yields, reaching 16.0 and 14.8 mg/g of plant dw for each
quercetin derivative by applying choline chloride based-deep eutectic
Fig. 1. HPLC phenolic profile of J. regia L. leaves. Graphical representation of walnut green sample, recorded at 280 nm (A) and 370 nm (B). The peaks identification
and quantification are presented in Table 1.
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solvents. Moreover, quercetin-3-O-galactoside was reported to be the
main flavonoid in Portuguese samples, and Amaral et al. (2004) ob-
tained concentrations from 5.15 to 14.90mg/g of plant dw, while
Pereira et al. (2007) found 15.72 to 21.68mg/g of plant dw, depending
on the J. regia cultivar. The abundancy in flavonols, specially quercetin
derivatives, is in good agreement with literature data (Amaral et al.,
2004; Cosmulescu et al., 2014; Pereira et al., 2007; Pitschmann et al.,
2014; Santos et al., 2013; Vieira et al., 2018, 2017; Zhao et al., 2014).
In addition, some walnut leaves also revealed the presence of other
flavonoids, such as taxifolin (flavanonol), epicatechin, laricitrin, and
procyanidin derivatives (Santos et al., 2013; Zhao et al., 2014).
3.2. Bioactivity of the hydroethanolic extracts
The antioxidant potential for the two phenological stages of the J.
regia leaves was assessed by two in vitro approaches: the inhibition of
the lipid peroxidation by the TBARS assay and the anti-haemolytic
activity through the OxHLIA assay. The obtained results are presented
in Table 2.
The kinetic behavior of the OxHLIA was similar to the previous
reported by Lockowandt et al. (2019). The heamolysis profile of the
assay using the green leaves extract is depicted in Fig. 2, representing
the dose-dependent effect to maintain the erythrocyte integrity. As the
graphical representation suggests, the heamolysis can be delayed by
increasing the extract concentration.
The green leaves extract showed the highest antioxidant potential
for both TBARS and OxHLIA assays, with lower IC50 values than the
yellow leaves extract. Regarding the OxHLIA assay, the protection of a
half of the erythrocyte population from the heamolysis was achieved by
using 32 ± 2 and 51 ± 2 μg/mL concentrations, for green and yellow
leaves extracts, respectively. The same tendency was observed for the
TBARS assay, with slightly lower IC50 values: 26.8 ± 0.2 and
48.5 ± 0.5 μg/mL, for green and yellow samples extracts, respectively.
The results of the TBARS assay for the green leaves extract is in good
agreement with the previous report of J. regia leaves methanolic extract
by Santos et al. (2013), presenting a IC50 of 20.36 ± 0.82 μg/mL.
Moreover, the antioxidant potential of the walnut leaf essential oil was
also evaluated, reaching 50% of TBARS inhibition formation with about
60 μg/mL (Rather et al., 2012).
The anti-haemolytic activity of walnut leaves was also evaluated by
Carvalho et al. (2010b), achieving IC50 values around 60 μg/mL after
3 h of reaction (Δt≈ 60min). Regarding the IC50 values for the positive
control (Trolox), they were lower than the ones obtained using the
extracts (19.6 ± 0.6 and 5.8 ± 0.6 μg/mL, for OxHLIA and TBARS
assays, respectively). That is, Trolox shows higher anti-haemolytic and
anti-peroxidation activities than the natural extracts. However, Trolox
is a pure antioxidant molecule while the extracts are composed by
several compounds with different bioactive actions. The extracts
showed a lower IC50 value for the TBARS assay compared with OxHLIA,
being closer to the positive control in the latter case. In fact, the IC50
values of the extracts are 1.6–2.6 times higher than Trolox ([sample]/
[Trolox]) in the OxHLIA assay, compared with the 4.2–8.4 times dif-
ference found for the TBARS assay.
The green leaves extract was the only sample showing inhibition of
the NO production up to the maximum concentrations tested 400 μg/
mL (Table 2). The concentration with the ability to inhibit 50% of the
nitric oxide production by the macrophages was found to be
319 ± 3 μg/mL. To the best of our knowledge, it is the first time that
the anti-inflammatory activity evaluation though an immune cells ap-
proach is made for this plant material. Nevertheless, the NO inhibition
production by walnut leaves extracts was previous studied as anti-
oxidant indicators. In this context, IC50 values of 1.95 ± 0.29 μg/mL
were obtained by measuring the NO generated by the NOC-5 (nitric
oxide amine-complex donor) decomposition. Moreover, Orhan et al.
(2011) quantified the radical scavenging activity of a series of extracts
obtained from different solvents (dichloromethane, ethyl acetate,
acetone, methanol and water), and the leaf water extract at 2000 μg/mL
was able to inhibit about 24% of the NO production. On the other hand,
some authors used mice models to perform the anti-inflammatory
evaluations. The carrageenan-induced paw edema in mice assay was
adopted by Erdemoglu et al. (2003), and showed potent anti-in-
flammatory activity for the ethanolic extract, achieving 67.9% of in-
hibitory ratios, without any gastric lesions. Later, Hosseinzadeh et al.
(2011) used the xylene-induced ear edema and the chronic inflamma-
tion (cotton-plate) test for the same purpose, achieving effective doses
in lower concentrations for the ethanolic extract of J. regia leaves than
the aqueous one. Overall, the data presented in this work demonstrate
the anti-inflammatory potential of ethanolic-based extracts of walnut
green leaves using a different method.
The results concerning the cytotoxic potential of the samples are
also presented in Table 2. Regarding the results for the tumor cell
cultures, the green leaves of J. regia showed a significant higher anti-
proliferative potential against to all the cell lines assessed. The most
susceptible cell culture was the HepG2 (hepatocellular carcinoma) one,
being a half of the cell proliferation inhibited by concentrations about
252 ± 10 to 260 ± 5 μg/mL (green and yellow samples, respectively),
while the NCI-H460 (non-small lung carcinoma) cells were the less
vulnerable ones (GI50 = 288 ± 5 and 328 ± 5 μg/mL, respectively,
for the green and yellow samples). Interestingly, a sample previously
studied from the same origin, did not present activity against these non-
small lung cancer cell line (GI50> 400 μg/mL) (Santos et al., 2013).
This fact is easily justified by environmental changes, which contribute
for phytochemical differences and then, slight variations in terms of
bioactivities. Even so, these results are very close to the previously
reported by the authors for methanolic and decoction extracts (Santos
et al., 2013). The proliferative inhibition of human renal (A-498 and
769-P) and colon (Caco-2) tumor cell lines was prior evaluated by
Carvalho et al. (2010b), achieving the walnut leaves methanolic ex-
tracts GI50 of 226, 352 and 229 μg/mL, respectively. Furthermore, the
extracts studied by Santos et al. (2013) also presented anti-proliferative
action against the human colon carcinoma (HCT-15) with GI50 of 215 to
Table 2
Antioxidant, anti-inflammatory, and cytotoxic activities of J. regia leaves ex-
tracts and positive controls (mean ± SD).
J. regia t-Students test p-
value
Green leaves Yellow leaves
Antioxidant activity (IC50 values μg/mL)
OxHLIA, Δt=60min 32 ± 2 51 ± 2 <0.001
TBARS formation inhibition 26.8 ± 0.2 48.5 ± 0.5 <0.001
Anti-inflammatory activity (EC50 values μg/mL)
Nitric oxide (NO) production 319 ± 13 >400 –
Cytotoxicity (GI50 μg/mL)
Tumor cell lines
MCF-7 (breast carcinoma) 268 ± 12 305 ± 5 0.143
NCI-H460 (non-small lung
carcinoma)
288 ± 5 328 ± 5 <0.001
HeLa (cervical carcinoma) 280 ± 8 312 ± 2 0.002
HepG2 (hepatocelular
carcinoma)
252 ± 10 260 ± 5 0.001
Non-tumor cells
PLP2 (porcine liver primary
culture)
> 400 >400 –
IC50: extract concentration corresponding to a 50% of antioxidant activity.
Trolox IC50 values: 19.6 ± 0.6 μg/mL (OxHLIA); 5.8 ± 0.6 μg/mL μg/mL
(TBARS inhibition). GI50 values correspond to the sample concentration re-
sponsible for 50% inhibition of growth in a cell culture. GI50 values for
Ellipticine (positive control): MCF-7: 1.21 ± 0.02 μg/mL; NCI-H460:
0.91 ± 0.11 μg/mL; HeLa: 1.03 ± 0.09 μg/mL; HepG2: 1.1 ± 0.09 μg/mL;
PLP2: 2.29 ± 0.18 μg/mL. EC50 values correspond to the sample concentration
responsible for 50% inhibition of NO production. EC50 values for dex-
amethasone (positive control): 16 ± 1 μg/mL.
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258 μg/mL (methanol extract and decoction, correspondingly).
Finally, the tested extracts did not reveal cytotoxicity for the pri-
mary liver porcine cells (PLP2) up to 400 μg/mL. These results are ac-
cording to the previous observations of Santos et al. (2013), for both
methanolic and decoction extracts. Besides the evidences about absence
of hepatotoxicity, a study performed by Eidi et al. (2013) showed a
positive effect over the liver in an in vivo model. The authors observed a
hepatoprotective effect in rats against the carbon tetrachloride (CCl4)
induced oxidation damage in rats by an aqueous-ethanolic extract.
The walnut leaves hydroethanolic extracts were also studied re-
garding their antimicrobial properties. To this end, five Gram-negative
(E. coli, K. pneumoniae, M. morganii, P. mirabilis, and P. aeruginosa) and
three Gram-positive (E. fecalis, L monocytogenes, and MRSA) bacteria
were selected. Data regarding the antibacterial activity of the extracts
are presented in Table 3. The obtained results do not vary between
samples, being the antibacterial potential of walnut leaves independent
of the maturity stage. Furthermore, those results suggest a selective
action against the Gram-positive strains. In fact, the achieved MIC va-
lues for the Gram-negative bacteria are about 20mg/mL (E. coli and K.
pneumoniae) or higher (M. morganii, P. mirabilis and P. aeruginosa),
while the results for the Gram-positive ones are considerably lower (≥
5mg/mL). The lowest MIC value (highest antibacterial activity) was
observed in E. faecalis and L. monocytogenes (MIC=2.5mg/mL).
Comparatively, the methicillin-resistant S. aureus (MRSA) was inhibited
with a higher concentration (MIC=5mg/mL). These findings allied to
the fact that none of the extracts showed MBC up to 20mg/mL, make J.
regia leaves extracts good candidates for applications aiming to estab-
lish the balance of natural flora caused by Gram-positive bacteria
proliferation. In this regard, the provided data of the present work,
endorse the proposal of Qa’dan et al. (2005) for the use of J. regia leaves
extracts for acne treatment.
In a previous study (also using bacteria from clinical isolates),
Pereira et al. (2007) also reported the preferable Gram-positive sus-
ceptibility of J. regia leaves aqueous extracts from different Portuguese
cultivars. The authors determined the MIC according to the agar streak
dilution method based on radial diffusion, reporting concentrations
about 0.1 to 1mg/mL able to inhibit the S. aureus growth. The extracts
were active against other Gram-positive bacteria (B. cereus and B.
Fig. 2. Kinetic profile of the action of J. regia green leaves extract during the erythrocyte heamolysis (OxHLIA assay).
Table 3
Antimicrobial activity (MIC and MBC mean values) of J. regia leaves extracts and positive controls.
Green leaves Yellow leaves Ampicillin (20mg/mL) Imipenem (1mg/mL) Vancomycin (1mg/mL)
MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC
Gram-negative bacteria
Escherichia coli 20 >20 20 >20 <0.15 < 0.15 < 0.0078 <0.0078 nt nt
Klebsiella pneumoniae 20 >20 20 >20 10 20 <0.0078 <0.0078 nt nt
Morganella morganii >20 >20 >20 >20 20 >20 <0.0078 <0.0078 nt nt
Proteus mirabilis >20 >20 >20 >20 <0.15 < 0.15 < 0.0078 <0.0078 nt nt
Pseudomonas aeruginosa >20 >20 >20 >20 >20 >20 0.5 1 nt nt
Gram-positive bacteria
Enterococcus faecalis 2.5 > 20 2.5 > 20 <0.15 <0.15 nt nt < 0.0078 <0.0078
Listeria monocytogenes 2.5 > 20 2.5 > 20 <0.15 <0.15 nt nt nt nt
MRSA* 5 > 20 5 >20 <0.15 <0.15 nt nt < 0.0078 <0.0078
MRSA- Methicillin Resistant Staphylococcus aureus; MIC: minimal inhibitory concentration; MBC: minimal bactericidal concentration; nt: not tested.
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subtilis), but not for the studied Gram-negative ones (P. aeruginosa, E.
coli and K. pneumonia). However, the study guided by Dolatabadi et al.
(2018) using Iranian walnut leaves (aqueous and methanolic) extracts
against clinical isolates of P. aeruginosa, revealed positive results. The
authors used the microdilution method, determining the MIC and MBC
of the samples by ELISA, achieving inhibitions with 4 and 8mg/mL and
bactericidal effect using 8 and 16mg/mL (aqueous and methanolic
extract, respectively). Iranian samples were also tested against other
Gram-positive strains by Sharafati-Chaleshtori et al. (2011). The au-
thors tested hydroethanolic extracts against face oral problematic
bacteria (S. mutans, S. salivarius, S. sanguinis and A. viscosus), obtaining
MIC values from 15.6 to 187.5 mg/mL and the MBC ranged from 31.25
to 250mg/mL. The problematic bacteria M. turbeculosis was success-
fully inhibited by Mexican (walnut leaves) methanolic extract, with
MIC values of 125 μg/mL. Finally, the bactericidal effect of Indian J.
regia leaves essential oil was also an object of study by Rather et al.
(2012), presenting lower MIC values against Gram-positive bacteria (B.
subtilis, S. epidermidis and S. aureus) than the Gram-negative ones (E.
coli, K. pneumonia, P. aeruginosa, P. vulgaris, S. typhi and S. dyssenteriae).
4. Conclusions
The Portuguese walnut leaves proved to be a good source of hy-
droxycinnamic acid derivatives and flavonols, especially trans 3-p-
coumaroylquinic acid and quercetin-3-O-glucoside. The former com-
pounds were abundant in green samples, while the later ones were
found in higher amounts in the yellow samples. The green leaves ex-
tract showed the highest antioxidant activity, being more capable to
inhibit the lipid peroxidation as well as the erythrocyte heamolysis.
Similarly, in the anti-inflammatory assay, only green samples presented
anti-inflammatory potential. It was also verified a cytotoxic effect
against tumor cell lines, but not for the non-tumor ones. Furthermore,
both extracts were active against Gram-positive bacteria. Overall, this
study shows the importance of walnut leaves as a source of bioactive
molecules, providing antioxidant, anti-inflammatory, anti-proliferative
and antibacterial properties, with potential to be used by different in-
dustries.
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